Vedolizumab (anti-α4β7-integrin)

Tax included
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
MedChemExpress 
HY-P9911A

Data sheet

Size
Multiple sizes
Reactivity
Integrin
Application
COVID-19-immunoregulation
CAS
943609-66-3